UK Brexit White Paper Would Keep Medtech Regulatory System – And Testing Just Once – Intact
It looks as if the EU medtech regulatory system could survive intact in the UK, given terms of the UK blueprint for its future relationship with the EU after separation. But a storm of controversy must be navigated first.
You may also be interested in...
In an urgent notice to clients, notified body BSI warns that time is running out to recertify against the current EU directives, as pressures mount for all notified bodies.
UK Brexit officials have been making positive noises at last about the proposals in the hoped-for trade deal that the UK is seeking for the post-EU period after March 29, 2019. But experience shows that the only certainty in Brexit is uncertainty, meaning several busy weeks ahead for those hammering out a UK-EU trade deal.
UK starts to discuss emergency measures around devices as no-deal Brexit concerns mount. But it is still looking like the UK will continue to implement the Medical Device Regulation, in the short-term at least. Will it be a different matter for the IVD Regulation?